tiprankstipranks
Advertisement
Advertisement
BDTX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBDTX Upcoming Earnings Report: What to Expect?
2M ago
Black Diamond Therapeutics price target lowered to $8 from $9 at Piper Sandler
Premium
The Fly
Black Diamond Therapeutics price target lowered to $8 from $9 at Piper Sandler
4M ago
Black Diamond Advances Silevertinib Combo Into Phase 2 for Hard‑to‑Treat Brain Cancer
Premium
Company Announcements
Black Diamond Advances Silevertinib Combo Into Phase 2 for Hard‑to‑Treat Brain Cancer
5M ago
Promising Potential of Silevertinib in EGFR-Mutant NSCLC: Buy Rating Reiterated
PremiumRatingsPromising Potential of Silevertinib in EGFR-Mutant NSCLC: Buy Rating Reiterated
6M ago
Black Diamond Reports Promising Phase 2 Lung Cancer Data
Premium
Company Announcements
Black Diamond Reports Promising Phase 2 Lung Cancer Data
6M ago
Black Diamond Therapeutics announces data from Phase 2 trial of silevertinib
Premium
The Fly
Black Diamond Therapeutics announces data from Phase 2 trial of silevertinib
6M ago
Black Diamond Therapeutics reports Q3 EPS (15c), consensus (23c)
PremiumThe FlyBlack Diamond Therapeutics reports Q3 EPS (15c), consensus (23c)
7M ago
Black Diamond Therapeutics sees cash runway into 4Q27
Premium
The Fly
Black Diamond Therapeutics sees cash runway into 4Q27
7M ago
Black Diamond Therapeutics resumed with a Buy at Stifel
Premium
The Fly
Black Diamond Therapeutics resumed with a Buy at Stifel
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100